European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

20 EU fundings (€17.6M): First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy … BdlYear 2025 EU Research and Innovation programme "Horizon"

Text

Kamer van Koophandel 64156338

01/05/2025 EU funding (€11.3M): Collaborative Action and Research for Engagement, Persistence and Adherence in Treatment & Health
01/01/2025 EU funding (€15.2M): Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development
24/01/2025 EU funding (€15M): EuroHeartPath: Leading Innovation in Cardiovascular Pathways for Improved Patient Outcomes
14/03/2025 EU funding (€194,075): Network mOdel for MechAnism of epilepsy Dynamics
31/03/2025 EU funding (€2,499,816): Smart Implant for Magnetic Anastomotic Healing and Leakage Evaluation
13/02/2025 EU funding (€2,999,934): Deciphering Alzheimer’s disease molecular subtypes to advance treatment development.
29/04/2025 EU funding (€217,076): TArgeting Multiphosphorylated tau in Blood for non-invasive Alzheimer's Disease diagnosis and staging
08/05/2025 EU funding (€25M): Diversibus Viis Plurima Solvo
09/07/2025 EU funding (€3,933,202): BIO-MICRO: Biomarkers and Intervention Outcomes in Micronutrient Optimization
01/07/2025 EU funding (€4,000,000): Implementation of an Integrated Care Model for Patients with Multiple Cardiometabolic and Mental Health Conditions in Sub-Saharan Africa
07/07/2025 EU funding (€4,017,473): A training network on glyconanomaterials as precision tools to unveil key insights on the triggering of the antigen presenting cells against cancer
08/07/2025 EU funding (€4,023,427): Transcending limitations of translational research on Multiple Sclerosis and Autism Spectrum Disorder - Spectral, brain-related disorder, patient outcomes, cognition, effect, symptoms
14/07/2025 EU funding (€4,251,589): Advancing in the CHallenge of Improving Lymphoma and LEukemia Survival
14/07/2025 EU funding (€4,482,132): UNderstanding Lipid ImmunoMetabolIsm To trEat Disease
09/07/2025 EU funding (€4,630,679): Investigation of biopsychoSocial Influences on Gender during diverse Hormonal Transitions
15/04/2025 EU funding (€432,468): Unravelling neuroimmune crosstalk to find novel treatment targets for inflammatory bowel disease
26/05/2025 EU funding (€7,499,754): An agentic, multi-layer, GenAI-powered backbone to make an AI system explainable, accountable, and transparent
19/09/2025 EU funding (€796,590): First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy
01/01/2025 EU funding (€8,501,477): Bridging Gaps in Mental Health Support: A Comprehensive European Strategy
08/05/2025 EU funding (€8,649,982): Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients
tax haven banner

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Stichting Amsterdam UMC, Amsterdam, Netherlands.

Creative Commons License The visualizations for "20 EU fundings (€17.6M): First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.